357 research outputs found
Cardiovascular Interactions Tutorial:An Update
The Cardiovascular Interaction (CVI) simulation model was developed by Carl Rothe (1929-2016) as an interactive computer simulation in the form of a tutorial. The original tutorial was based on a five-compartment model (Venous Bed, Right Heart, Lung Bed, Left Heart, and Arterial Bed). This work examines the simulation Dr. Rothe developed based on a six-compartment model (Systemic Veins, Right Ventricle, Pulmonary Arteries, Pulmonary Veins, Left Ventricle, and Systemic Arteries). Both models were originally developed in Visual Basic. Both models have been reimplemented in C# WPF for Windows and in LabVIEW for Windows 10 and Mac OS X
Developmental expression of a functional TASK-1 2P domain K+ channel in embryonic chick heart
<p>Abstract</p> <p>Background</p> <p>Background K<sup>+ </sup>channels are the principal determinants of the resting membrane potential (RMP) in cardiac myocytes and thus, influence the magnitude and time course of the action potential (AP).</p> <p>Methods</p> <p>RT-PCR and <it>in situ </it>hybridization are used to study the distribution of TASK-1 and whole-cell patch clamp technique is employed to determine the functional expression of TASK-1 in embryonic chick heart.</p> <p>Results</p> <p>Chicken TASK-1 was expressed in the early tubular heart, then substantially decreased in the ventricles by embryonic day 5 (ED5), but remained relatively high in ED5 and ED11 atria. Unlike TASK-1, TASK-3 was uniformly expressed in heart at all developmental stages. <it>In situ </it>hybridization studies further revealed that TASK-1 was expressed throughout myocardium at Hamilton-Hamburger stages 11 and 18 (S11 & S18) heart. In ED11 heart, TASK-1 expression was more restricted to atria. Consistent with TASK-1 expression data, patch clamp studies indicated that there was little TASK-1 current, as measured by the difference currents between pH 8.4 and pH 7.4, in ED5 and ED11 ventricular myocytes. However, TASK-1 current was present in the early embryonic heart and ED11 atrial myocytes. TASK-1 currents were also identified as 3 μM anandamide-sensitive currents. 3 μM anandamide reduced TASK-1 currents by about 58% in ED11 atrial myocytes. Zn<sup>2+ </sup>(100 μM) which selectively inhibits TASK-3 channel at this concentration had no effect on TASK currents. In ED11 ventricle where TASK-1 expression was down-regulated, I<sub>K1 </sub>was about 5 times greater than in ED11 atrial myocytes.</p> <p>Conclusion</p> <p>Functional TASK-1 channels are differentially expressed in the developing chick heart and TASK-1 channels contribute to background K<sup>+ </sup>conductance in the early tubular embryonic heart and in atria. TASK-1 channels act as a contributor to background K<sup>+ </sup>current to modulate the cardiac excitability in the embryonic heart that expresses little I<sub>K1</sub>.</p
A stochastic model for heart rate fluctuations
Normal human heart rate shows complex fluctuations in time, which is natural,
since heart rate is controlled by a large number of different feedback control
loops. These unpredictable fluctuations have been shown to display fractal
dynamics, long-term correlations, and 1/f noise. These characterizations are
statistical and they have been widely studied and used, but much less is known
about the detailed time evolution (dynamics) of the heart rate control
mechanism. Here we show that a simple one-dimensional Langevin-type stochastic
difference equation can accurately model the heart rate fluctuations in a time
scale from minutes to hours. The model consists of a deterministic nonlinear
part and a stochastic part typical to Gaussian noise, and both parts can be
directly determined from the measured heart rate data. Studies of 27 healthy
subjects reveal that in most cases the deterministic part has a form typically
seen in bistable systems: there are two stable fixed points and one unstable
one.Comment: 8 pages in PDF, Revtex style. Added more dat
Differential sensitivity of target genes to translational repression by miR-17~92
MicroRNAs (miRNAs) are thought to exert their functions by modulating the expression of hundreds of target genes and each to a small degree, but it remains unclear how small changes in hundreds of target genes are translated into the specific function of a miRNA. Here, we conducted an integrated analysis of transcriptome and translatome of primary B cells from mutant mice expressing miR-17~92 at three different levels to address this issue. We found that target genes exhibit differential sensitivity to miRNA suppression and that only a small fraction of target genes are actually suppressed by a given concentration of miRNA under physiological conditions. Transgenic expression and deletion of the same miRNA gene regulate largely distinct sets of target genes. miR-17~92 controls target gene expression mainly through translational repression and 5’UTR plays an important role in regulating target gene sensitivity to miRNA suppression. These findings provide molecular insights into a model in which miRNAs exert their specific functions through a small number of key target genesCX is a Pew Scholar in Biomedical
Sciences. This study is supported by the PEW
Charitable Trusts, Cancer Research Institute,
National Institute of Health (R01AI087634,
R01AI089854, RC1CA146299, R56AI110403, and
R01AI121155 to CX), National Natural Science
Foundation of China (31570882 to WHL, 31570883
to NX, 31570911 to GF, 91429301 to JH,
31671428 and 31500665 to YZ), 1000 Young
Talents Program of China (K08008 to NX), 100
Talents Program of The Chinese Academy of
Sciences (YZ), National Program on Key Basic
Research Project of China (2016YFA0501900 to
YZ), the Fundamental Research Funds for the
Central Universities of China (20720150065 to NX
and GF), Basic Science Research Program through
the National Research Foundation of Korea (NRF)
funded by the Ministry of Science, ICT & Future
Planning (NRF-2015R1C1A1A01052387 to SGK,
NRF-2016R1A4A1010115 to SGK and PHK), and
2016 Research Grant from Kangwon National
University (SGK)
Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival
Extent: 14 p.The dual specificity protein/lipid kinase, phosphoinositide 3-kinase (PI3K), promotes growth factor-mediated cell survival and is frequently deregulated in cancer. However, in contrast to canonical lipid-kinase functions, the role of PI3K protein kinase activity in regulating cell survival is unknown. We have employed a novel approach to purify and pharmacologically profile protein kinases from primary human acute myeloid leukemia (AML) cells that phosphorylate serine residues in the cytoplasmic portion of cytokine receptors to promote hemopoietic cell survival. We have isolated a kinase activity that is able to directly phosphorylate Ser585 in the cytoplasmic domain of the interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) receptors and shown it to be PI3K. Physiological concentrations of cytokine in the picomolar range were sufficient for activating the protein kinase activity of PI3K leading to Ser585 phosphorylation and hemopoietic cell survival but did not activate PI3K lipid kinase signaling or promote proliferation. Blockade of PI3K lipid signaling by expression of the pleckstrin homology of Akt1 had no significant impact on the ability of picomolar concentrations of cytokine to promote hemopoietic cell survival. Furthermore, inducible expression of a mutant form of PI3K that is defective in lipid kinase activity but retains protein kinase activity was able to promote Ser585 phosphorylation and hemopoietic cell survival in the absence of cytokine. Blockade of p110α by RNA interference or multiple independent PI3K inhibitors not only blocked Ser585 phosphorylation in cytokine-dependent cells and primary human AML blasts, but also resulted in a block in survival signaling and cell death. Our findings demonstrate a new role for the protein kinase activity of PI3K in phosphorylating the cytoplasmic tail of the GM-CSF and IL-3 receptors to selectively regulate cell survival highlighting the importance of targeting such pathways in cancer.Daniel Thomas, Jason A. Powell, Benjamin D. Green, Emma F. Barry, Yuefang Ma, Joanna Woodcock, Stephen Fitter, Andrew C.W. Zannettino, Stuart M. Pitson, Timothy P. Hughes, Angel F. Lopez, Peter R. Shepherd, Andrew H. Wei, Paul G. Ekert and Mark A. Guthridg
Measuring the impact of genetic heterogeneity and chromosomal inversions on the efficacy of CRISPR-Cas9 gene drives in different strains of Anopheles gambiae
The human malaria vector Anopheles gambiae is becoming increasingly resistant to insecticides, spurring the development of genetic control strategies. CRISPR-Cas9 gene drives can modify a population by creating double-stranded breaks at highly specific targets, triggering copying of the gene drive into the cut site (‘homing’), ensuring its inheritance. The DNA repair mechanism responsible requires homology between the donor and recipient chromosomes, presenting challenges for the invasion of lab-developed gene drives into wild populations of target species An. gambiae species complex, which show high levels of genome variation.
Two gene drives (vas2-5958 and zpg-7280) were introduced into three An. gambiae strains collected across Africa with 5.3-6.6% variation around the target sites, and the effect of this variation on homing was measured. Gene drive homing across different karyotypes of the 2La chromosomal inversion was also assessed. No decrease in gene drive homing was seen despite target site heterology, demonstrating the applicability of gene drives to wild populations
- …
